Page last updated: 2024-10-27

gabapentin and Bruxism

gabapentin has been researched along with Bruxism in 2 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Bruxism: A disorder characterized by grinding and clenching of the teeth.

Research Excerpts

ExcerptRelevanceReference
"Symptoms consistent with bruxism are a common chief complaint in dental practice."5.30Antidepressant-induced bruxism successfully treated with gabapentin. ( Brown, ES; Hong, SC, 1999)
"Symptoms consistent with bruxism are a common chief complaint in dental practice."1.30Antidepressant-induced bruxism successfully treated with gabapentin. ( Brown, ES; Hong, SC, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soyata, AZ1
Oflaz, S1
Brown, ES1
Hong, SC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Efficacy of Gabapentine and Splint Therapy in Bruxers: a Randomized Clinical Trial[NCT01255878]20 participants (Actual)Interventional2010-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for gabapentin and Bruxism

ArticleYear
Gabapentin Treatment in Bruxism Associated With Fluoxetine.
    Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:4

    Topics: Adult; Amines; Bruxism; Cyclohexanecarboxylic Acids; Female; Fluoxetine; Gabapentin; gamma-Aminobuty

2015
Antidepressant-induced bruxism successfully treated with gabapentin.
    Journal of the American Dental Association (1939), 1999, Volume: 130, Issue:10

    Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; B

1999